Email Alerts

Products Corporate Tissue Services

LifeCell's Technology

Research & Development

Investor Information

Career Opportunities

Regulatory Licensing Documentation

Quality Policy


	Investor Information

LifeCell's patented human tissue matrix, Alloderm®, has been successfully used in over 1 million grafts and implants to date, and a growing body of clinical evidence points to its potential use in a host of other surgical applications.

View Historical LifeCell
SEC Filings

View Historical LifeCell
Press Releases

LifeCell is pleased to announce that we have become a KCI Company. KCI is a global medical technology company with leadership positions in advanced wound care and therapeutic support systems. LifeCell will operate as a global biosurgery business within KCI. The acquisition of LifeCell by KCI combines two market leaders with complementary, best-in-class technologies who share a strong commitment to innovation and the commercialization of novel, medical solutions for health care professionals and their patients around the world.

Download Current Press Release

LifeCell is a KCI Company. You are leaving LifeCell.com and are being automatically directed to www.kci1.com